Personalized Cancer Therapy: Promise and Challenge with Razelle Kurzrock, MD

3/4/2015; 17 minutes

Genomics is a disruptive technology that enables personalized cancer therapy, while suggesting that old paradigms of clinical research and practice cannot work and must be changed. Razelle Kurzrock of the Moores Cancer Center shows how the impact of personalized cancer medicine is likely to be transformative—if the ethical, logistical, and technological challenges are addressed and overcome. Kurzrock is presented as part of the UC San Diego Founders Symposium 2014. Recorded on 11/13/2014. (#29033)

Links & Resources

More Programs With

 

SIGN UP FOR EMAIL UPDATES
Subscribe to receive email notifications about featured videos.
(c)2019 Regents of the University of California. All right reserved. Terms and Conditions of Use.